Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

Similar articles for PubMed (Select 20041446)

1.

The Japanese toxicogenomics project: application of toxicogenomics.

Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T.

Mol Nutr Food Res. 2010 Feb;54(2):218-27. doi: 10.1002/mnfr.200900169. Review.

PMID:
20041446
2.

Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.

Blomme EA, Yang Y, Waring JF.

Toxicol Lett. 2009 Apr 10;186(1):22-31. doi: 10.1016/j.toxlet.2008.09.017. Epub 2008 Oct 17. Review.

PMID:
18996174
3.

Toxicogenomics in predictive toxicology in drug development.

Suter L, Babiss LE, Wheeldon EB.

Chem Biol. 2004 Feb;11(2):161-71. Review.

4.

[Toxicogenomics as a tool for evaluation of chemical effects].

Watanabe H.

Yakugaku Zasshi. 2007 Dec;127(12):1967-74. Review. Japanese.

5.

Toxicogenomics in the assessment of immunotoxicity.

Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H.

Methods. 2007 Jan;41(1):132-41. Review.

PMID:
17161310
6.

Cross-species comparative toxicogenomics as an aid to safety assessment.

Mattes WB.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):859-74. Review.

PMID:
17125406
7.

The state-of-the-art in predictive toxicogenomics.

Fielden MR, Kolaja KL.

Curr Opin Drug Discov Devel. 2006 Jan;9(1):84-91. Review.

PMID:
16445120
8.

The use of toxicogenomic data in risk assessment: a regulatory perspective.

Chan VS, Theilade MD.

Clin Toxicol (Phila). 2005;43(2):121-6. Review.

PMID:
15822767
9.

[Toxicogenomics Project and drug safety evaluation.].

Urushidani T.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):46-9. Review. Japanese. No abstract available.

PMID:
20628214
10.

Toxicogenomics in drug discovery and development -- making an impact.

Wills Q, Mitchell C.

Altern Lab Anim. 2009 Sep;37 Suppl 1:33-7.

11.

Toxicogenomics in drug development.

Guerreiro N, Staedtler F, Grenet O, Kehren J, Chibout SD.

Toxicol Pathol. 2003 Sep-Oct;31(5):471-9. Review.

12.

Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.

Leighton JK.

Int J Toxicol. 2005 May-Jun;24(3):153-5. Review.

PMID:
16040567
13.

Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?

Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S.

Mutat Res. 2005 Aug 4;575(1-2):102-15. Epub 2005 Apr 25. Review.

PMID:
15924886
14.

Toxicogenomics in drug discovery: from preclinical studies to clinical trials.

Yang Y, Blomme EA, Waring JF.

Chem Biol Interact. 2004 Nov 1;150(1):71-85. Review.

PMID:
15522262
15.

Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.

Kienhuis AS, Bessems JG, Pennings JL, Driessen M, Luijten M, van Delft JH, Peijnenburg AA, van der Ven LT.

Toxicol Appl Pharmacol. 2011 Jan 15;250(2):96-107. doi: 10.1016/j.taap.2010.10.013. Epub 2010 Oct 21. Review.

PMID:
20970440
16.

Toxicogenomics: transcription profiling for toxicology assessment.

Zhou T, Chou J, Watkins PB, Kaufmann WK.

EXS. 2009;99:325-66. Review.

PMID:
19157067
17.

Application of microarray-based analysis of gene expression in the field of toxicogenomics.

Mei N, Fuscoe JC, Lobenhofer EK, Guo L.

Methods Mol Biol. 2010;597:227-41. doi: 10.1007/978-1-60327-389-3_16.

PMID:
20013237
18.

Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.

Currie RA, Orphanides G, Moggs JG.

Reprod Toxicol. 2005 Sep-Oct;20(3):433-40.

PMID:
15964738
19.

Toxicogenomics in risk assessment: applications and needs.

Boverhof DR, Zacharewski TR.

Toxicol Sci. 2006 Feb;89(2):352-60. Epub 2005 Oct 12. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk